These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1429 related items for PubMed ID: 24845488
1. Buprenorphine and methadone for opioid addiction during pregnancy. Mozurkewich EL, Rayburn WF. Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488 [Abstract] [Full Text] [Related]
2. Treatment of opioid dependence in the setting of pregnancy. Young JL, Martin PR. Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765 [Abstract] [Full Text] [Related]
3. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M. Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [Abstract] [Full Text] [Related]
4. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191 [Abstract] [Full Text] [Related]
6. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Jones HE, Finnegan LP, Kaltenbach K. Drugs; 2012 Apr 16; 72(6):747-57. PubMed ID: 22512363 [Abstract] [Full Text] [Related]
7. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E. Drug Alcohol Depend; 2013 Jan 01; 127(1-3):200-6. PubMed ID: 22841456 [Abstract] [Full Text] [Related]
8. Treatment of Perinatal Opioid Use Disorder. Boyars L, Guille C. Obstet Gynecol Clin North Am; 2018 Sep 01; 45(3):511-524. PubMed ID: 30092925 [Abstract] [Full Text] [Related]
9. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE. J Addict Med; 2017 Sep 01; 11(3):178-190. PubMed ID: 28406856 [Abstract] [Full Text] [Related]
10. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S, Martin PR. Am J Drug Alcohol Abuse; 2018 Sep 01; 44(3):310-316. PubMed ID: 28829626 [Abstract] [Full Text] [Related]
11. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G. Addiction; 2011 Jul 01; 106(7):1355-62. PubMed ID: 21438938 [Abstract] [Full Text] [Related]
14. Chronic opioid use during pregnancy: maternal and fetal implications. Stanhope TJ, Gill LA, Rose C. Clin Perinatol; 2013 Sep 01; 40(3):337-50. PubMed ID: 23972743 [Abstract] [Full Text] [Related]
15. Methadone and buprenorphine treatment during pregnancy: what are the effects on infants? Pritham UA, Troese M, Stetson A. Nurs Womens Health; 2007 Dec 01; 11(6):558-67. PubMed ID: 18088293 [No Abstract] [Full Text] [Related]
19. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M, Battin M, Walker E, Brown M, Abdelwahab M, Ma'ayeh M, Rood KM. J Matern Fetal Neonatal Med; 2022 Dec 01; 35(26):10481-10486. PubMed ID: 36202398 [Abstract] [Full Text] [Related]